Skip to content
Monday, November 16, 2026
Explore expert articles on digital transformation, innovati…

The Zimbabwean Government Turns Down ‘Lopsided’ US Healthcare Assistance Package Because of Information Fears

Medical funding image
The proposed American funding was intended for programmes for treating and preventing HIV/Aids, tuberculosis, and malarial diseases.

Zimbabwe has turned down a substantial US health deal worth 367 million US dollars (272 million pounds) spanning five years due to Washington's demand for confidential information.

This rejection became public following a internal memorandum from December was leaked, which showed President Emmerson Mnangagwa deemed the agreement was "skewed".

A government spokesperson has since stated that the US was seeking biological samples for scientific study and commercial purposes but was unwilling to share the resulting advantages from future treatments.

"We are forced to start the difficult and regrettable process of scaling back our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.

The US Embassy noted the United States had donated more than $1.9bn as health assistance to Zimbabwe during the past twenty years.

A physicians' group in Zimbabwe has called for continued negotiations to secure a agreement suitable to both sides so the nation's critical HIV programme can proceed.

Broader Background

Zimbabwe's decision follows a similar case in Kenya, where a court suspended a related deal with the US after legal challenges were filed about the safety of Kenyans' health data.

Since resuming office recently, US President Donald Trump has drastically cut foreign aid and shut down the key foreign aid agency.

USAID had managed aid for the US government, but Trump claimed its expenditure was "inefficient" and his administration was seeking direct bilateral deals to boost openness and responsibility.

Based on reports, Sixteen nations in Africa have so far signed these new health pacts, constituting more than $18.3bn in new funding.

Details of the Declined Deal

The money for Zimbabwe was intended to gone towards "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".

"It is our view this partnership would have delivered immense benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children presently receiving HIV treatment through US-supported initiatives," Tremont added.

However, government spokesperson Nick Mangwana argued the arrangement was "unequal".

"Zimbabwe was being asked to surrender its biological resources and data indefinitely, without any equivalent promise of access to any scientific breakthroughs – such as new medicines or tests – that could result from that provided information," his statement read.

"In essence, our nation would supply the basic resources for medical research with no assurance that the end products would be available to our people should a new health crisis emerge."

National Interest and International Frameworks

He also noted that the US's withdrawal from the global health body and its push of one-on-one health agreements were undermining frameworks previously established via the global health agency.

The spokesperson cited its Pathogen Access and Benefit Sharing system created to deal with future global health emergencies.

"This framework is designed to guarantee that when a country provides its samples, the benefits – such as vaccines and treatments – are shared equitably, not monopolised exclusively by those with the capability to create them."

These objections over the US deal "are not meant as anti-American sentiment," Mangwana stressed.

"We encourage ongoing dialogue with our US partners on how subsequent co-operation might be structured in a manner that honours the independence and dignity of each country."

Medical Community Response

Medical experts stated it acknowledged the government's concerns, but urged that talks should continue since a large portion of the country's Aids initiatives relied on foreign aid.

"Where technical issues arise, including those involving data governance or implementation frameworks, these can often be addressed through technical clarification and negotiated safeguards," the group added.

The halted deal underscores the ongoing debate between receiving much-needed foreign assistance and protecting national sovereignty in an ever more interconnected world.

PR
By

Patricia Richards

A technology strategist with over a decade of experience in digital innovation and business transformation across global enterprises.

HyperExchange Blog

Type to search articles.